logo
Select company
Select metric
$ -72.27MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
10
Sector
25
Industry
36
History
42
$ 20.66Close
$ 8.91 - $ 22.56 52-Week Range
Ticker Information

Ticker

ARCT

Company Name

ARCTURUS THERAPEUTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARCTURUS THERAPEUTICS HOLDINGS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARCT - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 3.31M$ -75.58M$ -72.27M
3/31/2025$ 3.44M$ -83.77M$ -80.33M
12/31/2024$ 3.54M$ -96.14M$ -92.6M
9/30/2024$ 3.54M$ -69.26M$ -65.72M
6/30/2024$ 3.46M$ -81.45M$ -78M
3/31/2024$ 3.28M$ -119.31M$ -116.03M
12/31/2023$ 2.96M$ -44.48M$ -41.52M
9/30/2023$ 2.69M$ 91.46M$ 94.16M
6/30/2023$ 2.28M$ 75.83M$ 78.11M
3/31/2023$ 1.88M$ 110.05M$ 111.93M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARCTURUS THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) EBITDA stands at $ -51.35M.
  • Over the past 5 years, ARCTURUS THERAPEUTICS HOLDINGS INC's average EBITDA has been $ -77.25M.
  • The median EBITDA for ARCTURUS THERAPEUTICS HOLDINGS INC during this period was $ -79.16M
  • ARCTURUS THERAPEUTICS HOLDINGS INC reached its highest EBITDA over the past 5 years at $ 111.93M.
  • The lowest EBITDA recorded by ARCTURUS THERAPEUTICS HOLDINGS INC in the same timeframe $ -200.56M

ARCTURUS THERAPEUTICS HOLDINGS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CTMX : CYTOMX THERAPEUTICS INC $ 54.08MADCT : ADC THERAPEUTICS SA $ -115.26MYMAB : Y-MABS THERAPEUTICS INC $ -26.3MRGNX : REGENXBIO INC $ -129.93MHRTX : HERON THERAPEUTICS INC $ 3.88MGLUE : MONTE ROSA THERAPEUTICS INC $ 36.76MTRDA : ENTRADA THERAPEUTICS INC $ -73MCDXS : CODEXIS INC $ -46.09MLFCR : LIFECORE BIOMEDICAL INC $ -8.81MSTIM : NEURONETICS INC $ -38.66M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ARCTURUS THERAPEUTICS HOLDINGS INC is calculated as follows: EBIT [ $ -51.57M ] + DepAmor [ $ 222K ]
(=) EBITDA [ $ -51.35M ]

ARCT - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -200.56M

Minimum

Dec 31, 2021

$ 111.93M

Maximum

Mar 31, 2023

$ -77.25M

Average

$ -79.16M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M